|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q3 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2018
As of Mar 31, 2018
|
Q2 FY2018
As of Dec 31, 2017
|
Q1 FY2018
As of Sep 30, 2017
|
Q4 FY2017
As of Jun 30, 2017
|
Q3 FY2017
As of Mar 31, 2017
|
Q2 FY2017
As of Dec 31, 2016
|
Q1 FY2017
As of Sep 30, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Total Current assets | ||||||||||||||||||||
| Non-Current assets: | ||||||||||||||||||||
| Prepaid investment in Apex North, LLC (see Notes 12 and 13) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Related party payable | ||||||||||||||||||||
| Dividend payable | ||||||||||||||||||||
| Notes payable and accrued interest | ||||||||||||||||||||
| Mandatorily redeemable preferred stock, at redemption value | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Convertible debentures | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ deficit: | ||||||||||||||||||||
| Common stock and paid in capital in excess of $0.001 par value, 2,000,000,000 shares authorized, 30,766,923 issued and outstanding as of March 31, 2026 and June 30, 2025 | ||||||||||||||||||||
| Series B Preferred stock and paid-in capital in excess of $0.001 par value, 20,000,000 shares authorized, 2 and 2 issued and outstanding as of March 31, 2026 and June 30, 2025 | ||||||||||||||||||||
| Share subscriptions and obligations to issue shares | ||||||||||||||||||||
| Common stock, $0.001 par value; 2,000,000,000 and1,000,000,000 shares authorized, respectively; 30,766,923 shares issued and outstanding at June 30, 2026 and 2025; | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 20,000,000 shares authorized, two Series B shares outstanding at June 30, 2026 and 2025, classified as liabilities; | ||||||||||||||||||||
| Additional paid-in capital - share obligations | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDER'S DEFICIT | ||||||||||||||||||||
Loading...
